Literature DB >> 23228400

Short- and intermediate-term survival after extracorporeal membrane oxygenation in children with cardiac disease.

Constantinos Chrysostomou1, Victor O Morell, Bradley A Kuch, Elizabeth O'Malley, Ricardo Munoz, Peter D Wearden.   

Abstract

OBJECTIVES: In children with cardiac disease, common indications for extracorporeal membrane oxygenation (ECMO) include refractory cardiopulmonary resuscitation (E-CPR), failure to separate from cardiopulmonary bypass (OR-ECMO), and low cardiac output syndrome (LCOS-ECMO). Despite established acceptance, ECMO outcomes are suboptimal with a survival between 38% and 55%. We evaluated factors associated with significantly increased survival in cardiac patients requiring ECMO.
METHODS: We conducted a retrospective investigation of consecutive patients undergoing ECMO between 2006 and 2010. Demographic, pre-ECMO, ECMO, and post-ECMO parameters were analyzed. Neurologic outcomes were assessed with the pediatric overall performance category scale at the latest follow-up.
RESULTS: There were 3524 admissions, 95 (3%) of which necessitated ECMO; 40 (42%) E-CPR, 31 (33%) OR-ECMO, and 24 (25%) LCOS-ECMO. The overall hospital survival was 73%. The within-groups hospital survival was 75% in E-CPR, 77% OR-ECMO and 62% LCOS-ECMO. In the multivariable logistic regression analysis, chromosomal anomalies (odds ratio [OR], 8; 95% confidence interval [CI], 2-35), single ventricle (OR ,6; 95% CI, 3-33), multiple ECMO runs (OR, 15; 95% CI, 4-42), higher 24-hour ECMO flows (OR, 8; 95% CI, 4-22), decreased lung compliance (OR, 5; 95% CI, 2-16), and need for plasma exchange (OR, 5; 95% CI, 3-18) were all significant factors associated with mortality. From the univariate analysis, a common parameter associated with mortality within all groups was intracranial hemorrhage. At 1.9 years (0.9, 2.9) of follow-up, 66% were still alive, and 89% of survivors had normal function or only mild neurodevelopmental disability.
CONCLUSIONS: ECMO was successfully used in children with cardiac disease with 73% and 66% short- and intermediate-term survival, respectively. The majority of the survivors had normal function or only a minimal neurodevelopmental deficit.
Copyright © 2013 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  20; 25; 41; ACT; APTT; CI; CPB; CPR; E-CPR; ECMO; LCOS; OR; OR-ECMO; POPC; Pediatric Overall Performance Category; VAD; activated clotting time; activated partial thromboplastin time; cardiopulmonary bypass; cardiopulmonary resuscitation; confidence interval; extracorporeal membrane oxygenation; failure to separate from cardiopulmonary bypass in the operating room; low cardiac output syndrome; odds ratio; refractory cardiopulmonary resuscitation; ventricular assist device

Mesh:

Year:  2012        PMID: 23228400     DOI: 10.1016/j.jtcvs.2012.11.014

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  18 in total

1.  Post-cardiotomy Rescue Extracorporeal Cardiopulmonary Resuscitation in Neonates with Single Ventricle After Intractable Cardiac Arrest: Attrition After Hospital Discharge and Predictors of Outcome.

Authors:  Anastasios C Polimenakos; Vincent Rizzo; Chawki F El-Zein; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2016-11-24       Impact factor: 1.655

2.  Clinical Factors Associated with Cerebral Metabolism in Term Neonates with Congenital Heart Disease.

Authors:  Anna Lonyai Harbison; Jodie K Votava-Smith; Sylvia Del Castillo; S Ram Kumar; Vince Lee; Vincent Schmithorst; Hollie A Lai; Sharon O'Neil; Stefan Bluml; Lisa Paquette; Ashok Panigrahy
Journal:  J Pediatr       Date:  2017-01-19       Impact factor: 4.406

3.  Outcomes of pediatric patients undergoing cardiac catheterization while on extracorporeal membrane oxygenation.

Authors:  Ryan Callahan; Sara M Trucco; Peter D Wearden; Lee B Beerman; Gaurav Arora; Jacqueline Kreutzer
Journal:  Pediatr Cardiol       Date:  2014-11-09       Impact factor: 1.655

4.  Trends in U.S. Extracorporeal Membrane Oxygenation Use and Outcomes: 2002-2012.

Authors:  Fenton H McCarthy; Katherine M McDermott; Vinay Kini; Jacob T Gutsche; Joyce W Wald; Dawei Xie; Wilson Y Szeto; Christian A Bermudez; Pavan Atluri; Michael A Acker; Nimesh D Desai
Journal:  Semin Thorac Cardiovasc Surg       Date:  2015-07-22

5.  Surfactant Administration During Pediatric Extracorporeal Membrane Oxygenation.

Authors:  Steven L Shein; Timothy M Maul; Hong Li; Geoffrey Kurland
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

6.  Use of Extracorporeal Membrane Oxygenation and Mortality in Pediatric Cardiac Surgery Patients With Genetic Conditions: A Multicenter Analysis.

Authors:  Jamie M Furlong-Dillard; Venugopal Amula; David K Bailly; Steven B Bleyl; Jacob Wilkes; Susan L Bratton
Journal:  Pediatr Crit Care Med       Date:  2017-09       Impact factor: 3.624

7.  Merging Two Hospitals: The Effects on Pediatric Extracorporeal Cardiopulmonary Resuscitation Outcomes.

Authors:  Rebecca Anderson de la Llana; Renate Le Marsney; Kristen Gibbons; Benjamin Anderson; Emma Haisz; Kerry Johnson; Anthony Black; Prem Sundar Venugopal; Adrian Christian Mattke
Journal:  J Pediatr Intensive Care       Date:  2020-08-31

8.  Neurologic Outcomes After Extracorporeal Membrane Oxygenation: A Systematic Review.

Authors:  Katharine Boyle; Ryan Felling; Alvin Yiu; Wejdan Battarjee; Jamie McElrath Schwartz; Cynthia Salorio; Melania M Bembea
Journal:  Pediatr Crit Care Med       Date:  2018-08       Impact factor: 3.624

9.  Clinical experience of more than 2 months usage of extracorporeal membrane oxygenation (Endumo(®)4000) without circuit exchange.

Authors:  Kunio Kusajima; Takaya Hoashi; Koji Kagisaki; Kotaro Yoshida; Takayuki Nishigaki; Teruyuki Hayashi; Hajime Ichikawa
Journal:  J Artif Organs       Date:  2013-12-31       Impact factor: 1.731

10.  Outcomes and factors associated with early mortality in pediatric and neonatal patients requiring extracorporeal membrane oxygenation for heart and lung failure.

Authors:  Farid Azizov; Julia Merkle; Javid Fatullayev; Kaveh Eghbalzadeh; Ilija Djordjevic; Carolyn Weber; Sergey Saenko; Axel Kroener; Mohamed Zeriouh; Anton Sabashnikov; Gerardus Bennink; Thorsten Wahlers
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.